News About: Pharm. Industry
Dongwha to market Fucidin in brailleDongwha Pharm said it will indicate the name of Fucidin, a popular wound protective, on the outer packaging in Braille to enable visually handicapped patients to recognize the p...
|
108 OTC items to exclude from health insurance
The government plans to ask the national health insurance not to cover 108 OTC items from 49 pharmaceutical firms, as part of its effort to stabilize the finance of the National Health Insurance Corporation.
Howeve...
Kyungnam Pharm poised to make inroads to US marketKyungnam Pharm said it will export its vitamin preparation Lemona to the United States in the first half of next year, as the product was already approved by the U.S. Food and D...
|
Johnson & Johnson Korea to create premier healthcare company
The Pfizer Consumer Healthcare business's acquisition will add a diverse portfolio of strong, growing, enduring brands that provide Johnson & Johnson Korea with leadership positions in nine additional categories, incl...
Smoking cessation aids market to be contested
Competition is about to heat up in the nation's anti-smoking therapy market as some companies are going head to head for a bigger share.
Smoking is a chronic relapsing medical condition that typically involves a ph...
Novartis Korea wins 2006 Korea Management AwardNovartis Korea received an award for personal management from the Korea Management Association at the Grand Hilton Seoul on December 5.
The prize has been awarded a person or...
|
Yuhan's new lip protective grabs bigger market share
Yuhan Corporation, the nation's leading drugmaker, is expanding its share of the domestic lip protective market dominated by international companies.
Backed by pharmacists and customers, Yuhan's new lip protective...
Once-daily Clarium (clarithromycin) to be available in Korea
There is good news for people with certain respiratory infections who require antibiotics but don't like the inconvenience of multiple daily dosing.
Sam-A Pharm said it has recently signed a licensing agreement wit...
Product approval process to be expedited
The new product approval process, which has been delayed due to the recent generic drugs' bioequivalence test data fabrication, may be facilitated by a newly formed task force team, according to the Korea Food and Dru...
GSK holds scientific symposium for Bonviva
GSK said on December 3 that it sponsored its scientific symposium for Bonviva (ibandronate), the first and only once-monthly tablet for the effective treatment of postmenopausal osteoporosis prior to its launching in ...
